<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><title>News on Pfizer Inc.</title><link href="http://liverdiseaseinfo.com/topic/pfizer-inc" rel="alternate"></link><id>http://liverdiseaseinfo.com/topic/pfizer-inc</id><updated>2010-10-27T06:53:34Z</updated><entry><title>Pfizer Ends Trial of Sutent in Liver Cancer</title><link href="http://liverdiseaseinfo.com/liver-diseases/pfizer-ends-trial-sutent-liver-cancer-3386542a" rel="alternate"></link><updated>2010-10-27T06:53:34Z</updated><author><name>Drugs.com</name></author><id>tag:liverdiseaseinfo.com,2010-10-27:/liver-diseases/pfizer-ends-trial-sutent-liver-cancer-3386542a/</id><summary type="html">...</summary><category term="Financial Markets"></category><category term="Stock Prices"></category><category term="Cancer"></category><category term="Kidney Cancer"></category><category term="Liver Cancer"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Pfizer Inc."></category><category term="Bayer AG"></category><category term="Sutent"></category><category term="Onyx Pharmaceuticals Inc."></category><category term="Nexavar"></category><category term="Stock Markets"></category></entry><entry><title>Pfizer ends trial of Sutent in liver cancer</title><link href="http://liverdiseaseinfo.com/liver-diseases/pfizer-ends-trial-sutent-liver-cancer-912894a" rel="alternate"></link><updated>2010-09-22T13:39:09Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-09-22:/liver-diseases/pfizer-ends-trial-sutent-liver-cancer-912894a/</id><summary type="html">&lt;div id="subtitle"&gt;&lt;a title="Pfizer Inc." href="/topic/Pfizer+Inc." &gt;Pfizer&lt;/a&gt; says &lt;a title="Sutent" href="/topic/Sutent" &gt;Sutent&lt;/a&gt; was not working better than Bayer's &lt;a title="Nexavar" href="/topic/Nexavar" &gt;Nexavar&lt;/a&gt; as a treatment for liver cancer&lt;/div&gt;&lt;div&gt;&lt;p&gt;Pfizer Inc. said Thursday it stopped a late-stage clinical study of its drug Sutent as a treatment for liver cancer.&lt;/p&gt;&lt;p&gt;Pfizer said patients who were treated with Sutent were not surviving as long as patients who were treated ...</summary><category term="Financial Markets"></category><category term="Stock Prices"></category><category term="Cancer"></category><category term="Liver Cancer"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Pfizer Inc."></category><category term="Bayer AG"></category><category term="Sutent"></category><category term="Onyx Pharmaceuticals Inc."></category><category term="Nexavar"></category><category term="Stock Markets"></category></entry><entry><title>Pfizer Settlement</title><link href="http://liverdiseaseinfo.com/photo/pfizer-settlement-1651693p" rel="alternate"></link><updated>2010-04-02T22:51:46Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-04-02:/photo/pfizer-settlement-1651693p/</id><summary type="html">&lt;a title="Federal Bureau of Investigation" href="/topic/Federal+Bureau+of+Investigation" &gt;FBI&lt;/a&gt; Assistant Director of Criminal Investigative Division &lt;a title="Kevin Perkins" href="/topic/Kevin+Perkins" &gt;Kevin Perkins&lt;/a&gt;, right, looks on as &lt;a title="Tom Perrelli" href="/topic/Tom+Perrelli" &gt;Associate Attorney General Tom Perrelli&lt;/a&gt;,  answers questions during a news conference to announce &lt;a title="Pfizer Inc." href="/topic/Pfizer+Inc." &gt;Pfizer&lt;/a&gt; will pay a record $2.3 billion civil and c...</summary><category term="Investigations"></category><category term="Criminal Investigations"></category><category term="United States"></category><category term="Federal Bureau of Investigation"></category><category term="Washington, DC"></category><category term="Pfizer Inc."></category><category term="Tom Perrelli"></category><category term="Kevin Perkins"></category></entry><entry><title>Pfizer CEO</title><link href="http://liverdiseaseinfo.com/photo/pfizer-ceo-543116p" rel="alternate"></link><updated>2010-04-14T10:37:58Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-04-14:/photo/pfizer-ceo-543116p/</id><summary type="html">&lt;a title="Jeffrey Kindler" href="/topic/Jeffrey+Kindler" &gt;Jeffrey Kindler&lt;/a&gt;, chairman and CEO of Pfizer, speaks at a news conference Monday, Jan. 26, 2009, in &lt;a title="New York" href="/topic/New+York" &gt;New York&lt;/a&gt;. Eager to dispel doubts about the difficulties of executing &lt;a title="Pfizer Inc." href="/topic/Pfizer+Inc." &gt;Pfizer Inc.&lt;/a&gt;'s $68 billion tie-up with Wyeth, Pfizer's CEO said it will be done more like microsurgery than just stitching two huge corporations together. (AP Photo/Mark...</summary><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="New York"></category><category term="Pfizer Inc."></category><category term="Jeffrey Kindler"></category></entry><entry><title>Pfizer to acquire Wyeth for $68 billion dollars</title><link href="http://liverdiseaseinfo.com/photo/pfizer-acquire-wyeth-68-billion-dollars-134000p" rel="alternate"></link><updated>2010-04-18T13:01:49Z</updated><author><name>ZUMA Press Inc</name></author><id>tag:liverdiseaseinfo.com,2010-04-18:/photo/pfizer-acquire-wyeth-68-billion-dollars-134000p/</id><summary type="html">epa01614571 &lt;a title="Jeffery Kindler" href="/topic/Jeffery+Kindler" &gt;Jeffery B. Kindler&lt;/a&gt;, Chairman and CEO of Pfizer (L) speaks as &lt;a title="Bernard Poussot" href="/topic/Bernard+Poussot" &gt;Bernard Poussot&lt;/a&gt;, Chairman and CEO of Wyeth listens at a press conference to announce that &lt;a title="Pfizer Inc." href="/topic/Pfizer+Inc." &gt;Pfizer&lt;/a&gt; will acquire Wyeth for approximately 8 billion dollars, at Pfizer headquarters in &lt;a title="New York" href="/topic/New+York" &gt;New York&lt;/a&gt;, &lt;a title="Un...</summary><category term="Company Activities and Information"></category><category term="Mergers and Acquisitions"></category><category term="Takeovers"></category><category term="Economic Issues"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Economic Crisis"></category><category term="United States"></category><category term="New York"></category><category term="Pfizer Inc."></category><category term="Bernard Poussot"></category><category term="BellSouth Corporation"></category><category term="Jeffery Kindler"></category></entry></feed>
